Stella Wilson's profile
Register date: March 25, 2021
14158003415
14158003415
User Description
Antibody
Drug Conjugates Market is estimated to be worth more than 15 billion in 2030,
predicts Roots Analysis
Antibody
drug conjugates (ADCs) represent a transformative approach to modern cancer
treatment; over the years, this upcoming class of targeted therapeutic agents
has generated significant enthusiasm within the medical science community.
Roots
Analysis is pleased to announce the publication of its recent study, titled, “Live Biotherapeutic Products and Microbiome
Contract Manufacturing Market,
2020-2030: Focus on Active Pharmaceutical Ingredients and Finished Dosage
Forms, 2020-2030.”
Manufacturing
live biotherapeutic product is both technically challenging and financially
demanding; as a result, innovator firms are becoming increasingly reliant on
contract service providers to access specialized facilities and optimize
overall costs.
Read
Detailed Analysis : https://www.rootsanalysis.com/reports/view_document/microbiome-contract-manufacturing/306.html
Large
Volume Wearable Injectors Market is estimated to be worth around USD 600
million by 2030, predicts Roots Analysis
More
than 40 large volume wearable injectors are presently available / under
development for the administration of drugs, beyond insulin, including 15+
drug-device combinations
Roots
Analysis is pleased to announce the publication of its recent study, titled,
“Global Handheld Ultrasound Imaging Devices
Market,
2021-2030”.
Handheld
Ultrasound Imaging Devices Market is projected to be over USD 1.1 billion by
2030, growing at a CAGR of 11%, claims Roots Analysis
Gene
Therapy Market is projected to grow at an annualized rate of 45%, till 2030
Encouraging
clinical results across various metabolic, hematological and ophthalmic
disorders have inspired research groups across the world to focus their efforts
on the development of novel gene editing therapies. In fact, the gene therapy
pipeline has evolved significantly over the past few years, with three products
being approved in 2019 alone; namely Beperminogene perplasmid (AnGes),
ZOLGENSMA® (AveXis) and ZYNTEGLO™ (bluebird bio).
Further, there are multiple pipeline candidates in mid to
late-stage (phase II and above) trials that are anticipated to enter the market
over the next 5-10 years.
The
USD 11.6 billion (by 2030) financial opportunity within the Gene Therapy Market
has been analyzed across the following segments:
Read
Detailed Report: https://www.rootsanalysis.com/reports/view_document/gene-therapies-market/268.html
Roots
Analysis is pleased to announce the publication of its recent study, titled, “Bispecific Antibody Therapeutics Market, 2021-2030.”
Bispecific
Antibody Therapeutics Market is estimated to be worth USD 6.9 billion in 2030,
predicts Roots Analysis
Bispecific
antibody therapeutics represent a transformative approach to modern treatment;
over the years, this upcoming class of ‘two-target’ artificially engineered
drugs have generated significant enthusiasm within the medical science
community
Read
Detailed Analysis: https://www.rootsanalysis.com/reports/view_document/bispecific-antibodies/286.html
Roots
Analysis is pleased to announce the publication of its recent study, titled, “Prefilled Syringe Fill / Finish Services
Market,
2021-2030.”
Prefilled
Syringe Fill / Finish Services Market is estimated to is estimated to reach
close to USD 3 Billion by 2030, predicts Roots Analysis
The
numerous benefits offered by prefilled syringes, coupled to the growing
self-medication trend, have led to the approval of a number of drugs in
combination with such devices, resulting in an increase in need to outsource
fill / finish operations
Ask
for Detailed Analysis:
https://www.rootsanalysis.com/reports/view_document/prefilled-syringe-fill-finish-services/301.html
Roots
Analysis is pleased to announce the
publication of its recent study, titled, “Patient Recruitment and Retention
Services Market,
2021-2030.”
Patient
Recruitment and Retention Services Market is estimated to be worth USD 5.3
billion in 2030
A
steadily increasing demand for participants in clinical research studies,
coupled to the complexities associated with patient enrolment, have prompted drug
/ therapy developers to outsource this process to specialty service providers
Roots Analysis is pleased to announce the publication of its recent study, titled, “Companion Diagnostics Development Services Market, 2020-2030”
Companion
Diagnostics Development Services Market is estimated to be worth over USD 800
million in 2030, predicts Roots Analysis
In
the last couple of years, a record number of personalized therapeutic products
were approved in the US, establishing an urgent need for companion diagnostics
and causing many drug developers to actively seek external support and
expertise.
For
more information, please visit https://www.rootsanalysis.com/reports/view_document/companion-diagnostics-services/297.html
Neoantigen
Targeted Therapies Market is estimated to be worth USD 3 Billion in 2030,
predicts Roots Analysis
Advances
in bioinformatics and genomic data analysis have enabled the identification of
cancer antigens that are generally overlooked during immune surveillance; these
neoantigens have been shown to possess substantial therapeutic potential
For
more information, please visit https://www.rootsanalysis.com/reports/view_document/neoantigen-targeted-therapies-market-2019-2030/257.html